% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Sowah:143619,
author = {S. A. Sowah$^*$ and L. Riedl$^*$ and A. Damms-Machado$^*$
and T. S. Johnson$^*$ and R. Schübel$^*$ and M. Graf$^*$
and E. Kartal and G. Zeller and L. Schwingshackl and G. I.
Stangl and R. Kaaks$^*$ and T. Kühn$^*$},
title = {{E}ffects of {W}eight-{L}oss {I}nterventions on
{S}hort-{C}hain {F}atty {A}cid {C}oncentrations in {B}lood
and {F}eces of {A}dults: {A} {S}ystematic {R}eview.},
journal = {Advances in nutrition},
volume = {10},
number = {4},
issn = {2156-5376},
address = {Bethesda, MD},
publisher = {ASN},
reportid = {DKFZ-2019-01196},
pages = {673-684},
year = {2019},
abstract = {Short-chain fatty acids (SCFAs, mainly acetate, propionate,
and butyrate), which are primarily derived from the gut
microbiome, may exert anti-inflammatory and immunomodulatory
effects, and regulate energy homeostasis. It has been
suggested that weight loss may affect SCFA metabolism, but a
systematic review of intervention studies is lacking. We
aimed to systematically assess the effects of dietary,
physical activity-based, and surgical weight-loss
interventions among overweight [body mass index (BMI)
25-29.9 kg/m2)] or obese (BMI ≥30 kg/m2) adults (≥18
y) on concentrations of acetate, propionate, butyrate, and
total SCFAs in blood, urine, or feces. We conducted a
systematic literature search in PubMed, Web of Science, and
the Cochrane Central Register of Controlled Trials (CENTRAL)
up to April 30, 2018 for randomized and nonrandomized
weight-loss trials among overweight or obese adults, in
which the concentrations of individual and total SCFAs were
assessed. A total of 9 studies consisting of 2 randomized
parallel-arm trials, 4 crossover trials, and 3 nonrandomized
clinical or surgical trials were included. In the majority
of studies, changes in fecal SCFA concentrations were
assessed, whereas changes in serum SCFAs were reported from
1 trial. Individual and total SCFA concentrations either
remained unchanged or decreased significantly following
weight loss. Three of the dietary interventions that
resulted in decreased SCFA concentrations were low $(≤5\%$
of energy) in total carbohydrates. Most of the studies had a
high risk of bias. Decreases in SCFA concentrations may
accompany weight loss induced by bariatric surgery or
dietary restriction among overweight or obese adults,
particularly when carbohydrate intake is reduced. However,
findings were inconsistent and based on studies with high to
unclear risk of bias, and small sample sizes. Because
measurements of fecal SCFAs may not be ideal due to limited
sample standardization, well-powered trials with repeated
blood measurements of SCFAs are required. This review was
registered at PROSPERO as CRD42018088716.},
subtyp = {Review Article},
cin = {C020},
ddc = {640},
cid = {I:(DE-He78)C020-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31075175},
doi = {10.1093/advances/nmy125},
url = {https://inrepo02.dkfz.de/record/143619},
}